Target Group, Inc. (Canada) (CBDY)

0.0008 0.00 (0.00%) USD  |  OTCM  |  Sep 23, 16:00
More

Target Group Total Return Level : 0.0008 for Sept. 23, 2026

Total Return Level Chart

View Total Return Level for CBDY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Return Level Chart
Start Trial

Historical Total Return Level Data

View and export this data back to 2015. Start Trial.
Date Value
September 23, 2026 0.0008
September 22, 2026 0.0008
September 21, 2026 0.0008
September 18, 2026 0.0008
September 17, 2026 0.0008
September 16, 2026 0.0011
September 15, 2026 0.0011
September 14, 2026 0.0011
September 11, 2026 0.0011
September 10, 2026 0.0011
September 09, 2026 0.0011
September 08, 2026 0.0011
September 04, 2026 0.0011
September 03, 2026 0.0011
September 02, 2026 0.001
September 01, 2026 0.001
August 31, 2026 0.0011
August 28, 2026 0.0012
August 27, 2026 0.0012
August 26, 2026 0.0012
August 25, 2026 0.0009
August 24, 2026 0.001
August 21, 2026 0.0012
August 20, 2026 0.0012
August 19, 2026 0.0012
Date Value
August 18, 2026 0.0012
August 17, 2026 0.0009
August 14, 2026 0.0012
August 13, 2026 0.0012
August 12, 2026 0.0012
August 11, 2026 0.0012
August 10, 2026 0.0012
August 07, 2026 0.0012
August 06, 2026 0.0012
August 05, 2026 0.0012
August 04, 2026 0.0012
August 03, 2026 0.0012
July 31, 2026 0.0012
July 30, 2026 0.0012
July 29, 2026 0.0012
July 28, 2026 0.0012
July 27, 2026 0.0012
July 24, 2026 0.0012
July 23, 2026 0.0012
July 22, 2026 0.0012
July 21, 2026 0.0012
July 20, 2026 0.0012
July 17, 2026 0.0009
July 16, 2026 0.0009
July 15, 2026 0.0012

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
Lexaria Bioscience Corp. 3.235
InMed Pharmaceuticals, Inc. 1.38
XORTX Therapeutics, Inc. 1.70
NervGen Pharma Corp. 1.96
Milestone Pharmaceuticals, Inc. 0.862